DoW Traumatic Brain Injury and Psychological Health, Clinical Trial Award
Dept. of the Army -- USAMRAA
Posted May 21, 2026
Description
<p><strong>Summary:</strong> The fiscal year 2026 (FY26) Traumatic Brain Injury and Psychological Health Research Program (TBIPHRP) Clinical Trial Award (CTA) intends to support clinical trials with the potential to have a significant impact on psychological health conditions and/or traumatic brain injury (TBI) through clinical applications, including health care products, technologies and/or practice guidelines. <strong style="color: rgb(0, 176, 80);"><em> </em></strong></p><p><strong>Distinctive Features:</strong><strong style="color: red;"> </strong>Funding from this award mechanism must support a clinical trial.</p><p>· Clinical trials may be designed to evaluate a wide range of interventions, including new drugs, biologics, medical devices, diagnostics, therapies and behavioral health strategies.</p><p>· Preliminary data are required.</p><p>· The inclusion of community-based participatory research (CBPR) approaches is required.</p><p>· The CTA offers funding for two Research Levels. The applicant is responsible for selecting the Research Level based on the scope of the research.</p><p>○ <strong>Research Level 1:</strong> Supports proof-of-principle pilot studies, as well as phase 1 and phase 2 clinical trials.</p><p>○ <strong>Research Level 2:</strong> Supports larger-scale and advanced clinical trials that evaluate effectiveness in relevant patient populations.</p><p>· <strong>Early-Career Investigator Partnering Option (<em>available for both Research Levels</em>):</strong> This option accommodates two Principal Investigators (PIs), one of which is an Early-Career Investigator. If recommended for funding, each PI will receive a separate award. </p><p><br></p><p><br></p>
AI Summary
The Traumatic Brain Injury and Psychological Health Research Program Clinical Trial Award funds clinical trials aimed at improving psychological health and addressing traumatic brain injury through various interventions, including drugs, devices, and therapies. Eligible applicants must have preliminary data and are encouraged to include community-based participatory research approaches; the program also allows for partnerships with early-career investigators.
Funding Details
Key Dates
Quick Facts
- CFDA Number
- 12.420
- Funder Type
- Federal Agency
- Grant Level
- FEDERAL
- Last Verified
- May 21, 2026
Geographic Scope
national
GL-D06184d061845c-ff97-4666-be6e-327e9c7ea098
Intelligence
Ready to apply?
Visit the funder's website to start your application.